Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioengineering
American Oriental Bioengineering, Inc. Announces Pricing of Convertible Notes Offering
July 27th, 2008
American Oriental Bioengineering, Inc. (NYSE:AOB) announced the pricing of a private offering of $115 million aggregate principal amount of Convertible Senior Notes due 2015 (the "Notes"). The Notes are being sold to qualified institutional buyers in a private placement exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The issuance of Notes is expected to close on July 15, 2008. The Notes will pay interest semiannually at a rate of five percent per annum. The Notes will be convertible at an initial conversion rate of 107.6195 shares per $1,000 principal amount of Notes, which is equal to an initial conversion...
Source: Pharma Investments, Ventures & Law Weekly (2008-07-27)
|
